Clinical Trials Directory

Trials / Completed

CompletedNCT03357718

Oral Dexmedetomidine vs Midazoam For Premedication

Oral Dexmedetomidine vs Midazoam For Premedication And Emergence Delirium in Children Undergoing Dental Treatment

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Aydin Adnan Menderes University · Academic / Other
Sex
All
Age
3 Years – 7 Years
Healthy volunteers
Accepted

Summary

The aim of this study was to compare the effect of 2 µg/kg of oral dexmedetomidine (DEX) and 0.5 mg/kg dormicum as premedication among children undergoing dental procedures.

Detailed description

The study involved 52 children between 3-7 years of age, ASA I , who underwent full-mouth dental rehabilitation. The DEX group (n=26) received 2 µg/kg DEX in apple juice, and the control group (n=26) received 0.5 mg/kg midazolam in apple juice. The patients' scores on the Ramsey sedation scale (RSS), parental separation anxiety scale, mask acceptance scale, post-anesthesia emergence delirium scale (PAEDS), and hemodynamic parameters were recorded. The data were analyzed using chi-square test, Fisher's exact test, student t test, and analysis of variance in SPSS.

Conditions

Interventions

TypeNameDescription
DRUGPrecedex2 µg/kg oral
DRUGMidazolam0.5 mg/kg

Timeline

Start date
2016-11-01
Primary completion
2017-05-30
Completion
2017-06-01
First posted
2017-11-30
Last updated
2020-05-29

Source: ClinicalTrials.gov record NCT03357718. Inclusion in this directory is not an endorsement.